Stock ICLR ICON PUBLIC LIMITED COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Other languages ICON Public Limited Company

Equities

ICLR

IE0005711209

Real-time Estimate Cboe BZX
Other stock markets
 08:23:14 29/04/2024 pm IST 		5-day change 1st Jan Change
305.6 USD -0.88% Intraday chart for ICON Public Limited Company +2.70% +8.09%
26/04 UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating MT
25/04 Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed
ICON Public Limited Company Reports Earnings Results for the First Quarter Ended March 31, 2024
Icon Says CFO Brennan Leaving in Q4, Reaffirms Guidance
Icon plc Reaffirm Earnings Guidance for the Year 2024
ICON Shares Rise After Q4 Results, Guidance Reaffirmed
ICON Seeks M&A
ICON Q4 Adjusted Earnings, Revenue Increase; 2024 Guidance Affirmed
ICON Public Limited Company announces an Equity Buyback for $500 million worth of its shares.
ICON Public Limited Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
ICON Public Limited Company Reaffirms Earnings Guidance for the Full Year 2024
ICON Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2023
RECOMENDACIONES DE LOS ANALISTAS EE.UU. : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....
ICON Public Limited Company authorizes a Buyback Plan.
ICON Public Limited Company Provides Earnings Guidance for the Full Year 2023 and 2024
ICON Seeks Acquisitions
ICON Q3 Adjusted EPS, Revenue Rise; Full-Year Guidance Disclosed
Icon Public Limited Company Re-Affirms Earnings Guidance for the Full-Year 2023
ICON Public Limited Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
ICON Public Limited Company completed the acquisition of Philips Pharma Solutions for $68.1 million.
ICON plc Releases Expanded End-To-End Clinical Trial Tokenisation Solution
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ICLR Stock
  4. News ICON Public Limited Company
  5. Other languages